Bree Duncan, RN, BSN, on a team-based approach to bladder cancer care
“When it comes to this, I think having a great team around you is really so important,” says Bree Duncan, RN, BSN.
In this video, Bree Duncan, RN, BSN, Gail Kraemer Care Coordinator for Female Bladder Cancer Patients at Vanderbilt University Medical Center in Nashville, Tennessee, shares how she collaborates with the entire care team.
Transcription:
Is there anything else you would like to add?
When it comes to this, I think having a great team around you is really so important. I couldn't do this without having the support of the doctors and the support of the clinic staff and the nurses that work with these patients, because if they do get phone calls or something, they get a patient that maybe I didn't get a chance to catch on the schedule, them calling me, being like, "hey, we have this patient," because I can't always be there. And so having their support to help make sure I'm reaching out to as many women as possible is really important. And they're also a great resource to me for when I don't know the answers to certain questions that come up. Being a nurse really helps, because I do get a lot of nursing questions where, being a urology nurse, hopefully I can answer those easily for them. But there are going to be things that come up that I don't know the answer to and so having the close relationship with all of the staff and the providers really helps streamline that process and get answers quickly for these patients.
This transcription was edited for clarity.
Coding Q&A: Billing for female total urethrectomy with complete cystectomy
January 5th 2024"When we think about a typical procedure for performing a radical cystectomy for cancer with an ileal conduit, that would typically involve lymph node dissection, and therefore CPT 51595 would be best chosen to report that combined procedure," write Jonathan Rubenstein, MD, and Mark Painter.
Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app
December 7th 2021“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
